Roche CA - Search Results

1

Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.

Euhus DM, Smith KC, Robinson L, Stucky A, Olopade OI, Cummings S, Garber JE, Chittenden A, Mills GB, Rieger P, Esserman L, Crawford B, Hughes KS, Roche CA, Ganz PA, Seldon J, Fabian CJ, Klemp J, Tomlinson G. Euhus DM, et al. Among authors: roche ca. J Natl Cancer Inst. 2002 Jun 5;94(11):844-51. doi: 10.1093/jnci/94.11.844. J Natl Cancer Inst. 2002. PMID: 12048272

2

The complexity of breast cancer risk needs to be embraced, not oversimplified.

Hughes KS, Roche CA. Hughes KS, et al. Among authors: roche ca. Menopause. 2011 Jun;18(6):599-600. doi: 10.1097/gme.0b013e31821bbd55. Menopause. 2011. PMID: 21587090 No abstract available.

3

Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers.

Drohan B, Roche CA, Cusack JC Jr, Hughes KS. Drohan B, et al. Among authors: roche ca. Ann Surg Oncol. 2012 Jun;19(6):1732-7. doi: 10.1245/s10434-012-2257-y. Epub 2012 Mar 17. Ann Surg Oncol. 2012. PMID: 22427173 Review.

4

How do we apply genetic testing for breast cancer susceptibility to clinical practice?

Hughes KS, Roche CA. Hughes KS, et al. Among authors: roche ca. J Surg Oncol. 1996 Jul;62(3):155-7. doi: 10.1002/(SICI)1096-9098(199607)62:3<155::AID-JSO1>3.0.CO;2-6. J Surg Oncol. 1996. PMID: 8667620 No abstract available.

5

The effectiveness of the Gail model in estimating risk for development of breast cancer in women under 40 years of age.

MacKarem G, Roche CA, Hughes KS. MacKarem G, et al. Among authors: roche ca. Breast J. 2001 Jan-Feb;7(1):34-9. doi: 10.1046/j.1524-4741.2001.007001034.x. Breast J. 2001. PMID: 11348413

6

Evaluation of hereditary risk in a mammography population.

Jones JL, Hughes KS, Kopans DB, Moore RH, Howard-McNatt M, Hughes SS, Lee NY, Roche CA, Siegel N, Gadd MA, Smith BL, Michaelson JS. Jones JL, et al. Among authors: roche ca. Clin Breast Cancer. 2005 Apr;6(1):38-44. doi: 10.3816/CBC.2005.n.007. Clin Breast Cancer. 2005. PMID: 15899071

7

Hormone therapy revisited: data from the population, treatment for the patient.

Hughes KS, Roche CA. Hughes KS, et al. Among authors: roche ca. Menopause. 2003 Jul-Aug;10(4):269-70. doi: 10.1097/01.GME.0000079503.41032.AE. Menopause. 2003. PMID: 12851507 No abstract available.

8

Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire.

Hughes KS, Roche C, Campbell CT, Siegel N, Salisbury L, Chekos A, Katz MS, Edell E. Hughes KS, et al. Breast J. 2003 Jan-Feb;9(1):19-25. doi: 10.1046/j.1524-4741.2003.09105.x. Breast J. 2003. PMID: 12558666

9

Support needs and acceptability of psychological and peer consultation: attitudes of 108 women who had undergone or were considering prophylactic mastectomy.

Patenaude AF, Orozco S, Li X, Kaelin CM, Gadd M, Matory Y, Mayzel K, Roche CA, Smith BL, Farkas W, Garber JE. Patenaude AF, et al. Among authors: roche ca. Psychooncology. 2008 Aug;17(8):831-43. doi: 10.1002/pon.1279. Psychooncology. 2008. PMID: 18636423 Free PMC article.

10

Chemoprevention acceptance and adherence in women with high-risk breast lesions.

Roche CA, Tang R, Coopey SB, Hughes KS. Roche CA, et al. Breast J. 2019 Mar;25(2):190-195. doi: 10.1111/tbj.13064. Epub 2018 May 21. Breast J. 2019. PMID: 29785770

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters